PPF66 Developing a palliative care service for patients with liver disease

Read full text Summarise with VIRAT
Authors: Maria K. McKenna, Wendy Honey, Laura Jopson
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Background Patients with end-stage liver disease (ESLD) are an underserved population, with a high symptom and caregiver burden, who commonly die in hospital. Data suggests ESLD typically makes up 1% of a hospital based palliative care service (PCS) caseload(1). Method We describe an innovative service development aiming to improve palliative care provision in ESLD, within a single UK centre providing tertiary level hepatology care, through: • Identification of palliative care need through routine PCS attendance of weekly hepatology departmental grand round • Earlier holistic assessment by PCS • Implementation of a monthly combined hepatology-PCS MDT meeting Results 44 patients were reviewed by the PCS over a 6 month period (April-September 2025), making up almost 10% of referrals to this hospital-based PCS over the time period (44/467). • 36 (82%) were seen as inpatients and 8 as outpatients • Median age was 64 years(range 34-94) • Following holistic PCS assessment of the 36 inpatients: o 16 (44%) died in hospital o 10 (28%) were discharged home o 5 (14%) were discharged to hospice o 4 (11%) were discharged to a care home o 1 (3%) was discharged from ongoing PCS review • Of the 14 patients discharged home or to a care home: o 13/14 (93%) had a DNACPR decision documented o 10/14 (71%) had an Emergency Health Care Plan (established regional document) o 10/14 (71%) had advance care planning (ACP) discussions documented on PCS discharge letter o 1 declined ACP discussions • Preferred place of care was identified for 83% (30/36) inpatients assessed and achieved in 26/30 (87%). • When preferred place of death was known, it was achieved in 75% deaths (n=24). Conclusion This service development has markedly improved identification of patients with ESLD and palliative care need, rates of holistic assessment and ACP. There remains a need to identify patients with ESLD earlier in their disease trajectory.

Fields of Study & Subjects

Palliative Care and End-of-Life Issues Palliative and Oncologic Care Liver Disease and Transplantation

Publication details

Journal / source
BMJ Supportive & Palliative Care
Pages
A68.3–A69
Publication date
25 March 2026
Language
EN